Pilocarpine for radiotherapy-Induced dry mouth and dry eyes a review of clinical effectiveness, cost-effectiveness, and guidelines
The objective of this report is to summarize the evidence regarding the clinical effectiveness, cost-effectiveness, and evidence-based guidelines regarding the use of pilocarpine for the treatment of dry mouth and dry eyes caused by radiotherapy for cancer of the head or neck
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2020, January 8, 2020
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this report is to summarize the evidence regarding the clinical effectiveness, cost-effectiveness, and evidence-based guidelines regarding the use of pilocarpine for the treatment of dry mouth and dry eyes caused by radiotherapy for cancer of the head or neck |
|---|---|
| Physical Description: | 1 PDF file (22 pages) illustrations |